Literature DB >> 35596897

Diffusely infiltrating glioma with CREBBP-BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report.

Ayako Yamazaki1, Yasuhito Arai2, Kohei Fukuoka3, Yoshiko Nakano4,5, Natsuko Hama2, Satoshi Nakata6, Keishi Makino7, Jun-Ichiro Kuroda8, Naoki Shinojima8, Akitake Mukasa8, Yoshiki Mikami9, Koichi Ichimura10, Tatsuhiro Shibata2, Hideaki Yokoo1, Sumihito Nobusawa11.   

Abstract

BCORL1 encodes a transcriptional corepressor homolog to BCOR. BCORL1 rearrangements have been previously described as rare events, and among them, CREBBP-BCORL1 has been reported only in 2 cases of ossifying fibromyxoid tumors. Herein, we present the first case of diffusely infiltrating glioma with CREBBP-BCORL1 involving a 17-year-old female patient. Histologically, the tumor was composed of a diffusely infiltrative proliferation of small tumor cells with moderate cellularity showing prominent microcystic formation. DNA methylation analysis revealed that the current case and a previously reported anaplastic ependymoma with EP300-BCORL1 were clustered together in close proximity to but distinct from methylation class high-grade neuroepithelial tumor with BCOR alteration. RNA sequencing demonstrated high mRNA expression of not only BCORL1 but BCOR, and the latter was compatible with diffuse nuclear expression of BCOR detected by immunohistochemistry. Our findings suggest that central nervous system tumors with CREBBP/EP300-BCORL1 may exhibit diverse morphologies but form a distinct DNA methylation group and that BCORL1 fusion genes may lead to upregulation of both BCOR and BCORL1.
© 2022. The Author(s), under exclusive licence to The Japan Society of Brain Tumor Pathology.

Entities:  

Keywords:  BCOR; BCORL1; CREBBP; EP300; Glioma

Year:  2022        PMID: 35596897     DOI: 10.1007/s10014-022-00435-4

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  8 in total

Review 1.  Acetylation: a regulatory modification to rival phosphorylation?

Authors:  T Kouzarides
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

2.  A novel corepressor, BCoR-L1, represses transcription through an interaction with CtBP.

Authors:  Julia K Pagan; Jeremy Arnold; Kim J Hanchard; Raman Kumar; Tiziana Bruno; Mathew J K Jones; Derek J Richard; Alistair Forrest; Amanda Spurdle; Eric Verdin; Merlin Crossley; Maurizio Fanciulli; Georgia Chenevix-Trench; David B Young; Kum Kum Khanna
Journal:  J Biol Chem       Date:  2007-03-22       Impact factor: 5.157

3.  High-resolution characterization of a hepatocellular carcinoma genome.

Authors:  Yasushi Totoki; Kenji Tatsuno; Shogo Yamamoto; Yasuhito Arai; Fumie Hosoda; Shumpei Ishikawa; Shuichi Tsutsumi; Kohtaro Sonoda; Hirohiko Totsuka; Takuya Shirakihara; Hiromi Sakamoto; Linghua Wang; Hidenori Ojima; Kazuaki Shimada; Tomoo Kosuge; Takuji Okusaka; Kazuto Kato; Jun Kusuda; Teruhiko Yoshida; Hiroyuki Aburatani; Tatsuhiro Shibata
Journal:  Nat Genet       Date:  2011-04-17       Impact factor: 38.330

4.  The transcriptional coactivators p300 and CBP are histone acetyltransferases.

Authors:  V V Ogryzko; R L Schiltz; V Russanova; B H Howard; Y Nakatani
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

5.  Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.

Authors:  Yu-Chien Kao; Yun-Shao Sung; Lei Zhang; Chun-Liang Chen; Shih-Chiang Huang; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2016-08-26       Impact factor: 5.006

6.  Central nervous system high grade neuroepithelial tumor with BCOR immunopositivity: Is there a molecular heterogeneity?

Authors:  Shilpa Rao; Saikat Mitra; Harsha Sugur; Vikas Vazhayil; B Ravi Mohan Rao; Santosh Kumar Annayappa; B N Nandeesh; T C Yasha; Vani Santosh
Journal:  Brain Tumor Pathol       Date:  2020-09-27       Impact factor: 3.298

7.  PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.

Authors:  Felix Sahm; Karam T Alhalabi; Damian Stichel; Philipp Sievers; Heike Peterziel; Alexander C Sommerkamp; Dominik Sturm; Andrea Wittmann; Martin Sill; Natalie Jäger; Pengbo Beck; Kristian W Pajtler; Matija Snuderl; George Jour; Michael Delorenzo; Allison M Martin; Adam Levy; Nagma Dalvi; Jordan R Hansford; Nicholas G Gottardo; Emmanuelle Uro-Coste; Claude-Alain Maurage; Catherine Godfraind; Fanny Vandenbos; Torsten Pietsch; Christof Kramm; Maria Filippidou; Antonis Kattamis; Chris Jones; Ingrid Øra; Torben Stamm Mikkelsen; Michal Zapotocky; David Sumerauer; David Scheie; Martin McCabe; Pieter Wesseling; Bastiaan B J Tops; Mariëtte E G Kranendonk; Matthias A Karajannis; Nancy Bouvier; Elli Papaemmanuil; Hildegard Dohmen; Till Acker; Katja von Hoff; Simone Schmid; Evelina Miele; Katharina Filipski; Lidija Kitanovski; Lenka Krskova; Johannes Gojo; Christine Haberler; Frank Alvaro; Jonas Ecker; Florian Selt; Till Milde; Olaf Witt; Ina Oehme; Marcel Kool; Andreas von Deimling; Andrey Korshunov; Stefan M Pfister; David T W Jones
Journal:  Acta Neuropathol       Date:  2021-08-21       Impact factor: 17.088

8.  Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: A hitherto unclassified tumor related to ependymoma.

Authors:  Ran Tomomasa; Yasuhito Arai; Reika Kawabata-Iwakawa; Kohei Fukuoka; Yoshiko Nakano; Natsuko Hama; Satoshi Nakata; Nozomi Suzuki; Yukitomo Ishi; Shinya Tanaka; Jun A Takahashi; Yoshiaki Yuba; Mitsutaka Shiota; Atsushi Natsume; Michihiro Kurimoto; Yoshiki Shiba; Mikiko Aoki; Kazuki Nabeshima; Toshiyuki Enomoto; Tooru Inoue; Junya Fujimura; Akihide Kondo; Takashi Yao; Naoki Okura; Takanori Hirose; Atsushi Sasaki; Masahiko Nishiyama; Koichi Ichimura; Tatsuhiro Shibata; Junko Hirato; Hideaki Yokoo; Sumihito Nobusawa
Journal:  Brain Pathol       Date:  2021-02-12       Impact factor: 6.508

  8 in total
  1 in total

1.  Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.

Authors:  Zhichao Wu; Sharika Rajan; Hye-Jung Chung; Mark Raffeld; Pavalan Panneer Selvam; Leonille Schweizer; Arie Perry; David Samuel; Caterina Giannini; Aditya Ragunathan; Matthew P Frosch; Michael S Marshall; Daniel R Boué; Kliment Donev; Stewart G Neill; Igor Fernandes; Adam Resnick; Brian Rood; Thomas J Cummings; Anne F Buckley; Linda Szymanski; Osorio Lopes Abath Neto; Leor Zach; Howard Colman; Samuel Cheshier; Jennifer Ziskin; Manoj Tyagi; David Capper; Zied Abdullaev; Patrick J Cimino; Martha Quezado; Drew Pratt; Kenneth Aldape
Journal:  Acta Neuropathol       Date:  2022-10-06       Impact factor: 15.887

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.